Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1978 1
1979 4
1980 1
1981 3
1982 3
1983 2
1984 5
1986 3
1987 2
1988 8
1989 9
1990 6
1991 3
1992 7
1993 4
1994 8
1995 10
1996 4
1997 4
1998 8
1999 9
2000 7
2001 8
2002 5
2003 4
2004 11
2005 7
2006 5
2007 3
2008 10
2009 9
2010 6
2011 10
2012 9
2013 8
2014 4
2015 8
2016 13
2017 11
2018 12
2019 12
2020 15
2021 15
2022 12
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Results by year

Filters applied: . Clear all
Page 1
Synthetic hydrogels as drug delivery systems.
Roorda WE, Boddé HE, De Boer AG, Bouwstra JA, Junginer HE. Roorda WE, et al. Among authors: de boer ag. Pharm Weekbl Sci. 1986 Jun 20;8(3):165-89. doi: 10.1007/BF01959775. Pharm Weekbl Sci. 1986. PMID: 3526277 Review.
Blood-brain barrier dysfunction and recovery.
de Boer AG, Gaillard PJ. de Boer AG, et al. J Neural Transm (Vienna). 2006 Apr;113(4):455-62. doi: 10.1007/s00702-005-0375-4. J Neural Transm (Vienna). 2006. PMID: 16550324 Review.
Improvement of drug absorption through enhancers.
de Boer AG, van Hoogdalem EJ, Breimer DD. de Boer AG, et al. Eur J Drug Metab Pharmacokinet. 1990 Apr-Jun;15(2):155-7. doi: 10.1007/BF03190198. Eur J Drug Metab Pharmacokinet. 1990. PMID: 2200684 Review.
Targeted delivery across the blood-brain barrier.
Gaillard PJ, Visser CC, de Boer AG. Gaillard PJ, et al. Among authors: de boer ag. Expert Opin Drug Deliv. 2005 Mar;2(2):299-309. doi: 10.1517/17425247.2.2.299. Expert Opin Drug Deliv. 2005. PMID: 16296755 Review.
The blood-brain barrier in neuroinflammatory diseases.
de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD. de Vries HE, et al. Among authors: de boer ag. Pharmacol Rev. 1997 Jun;49(2):143-55. Pharmacol Rev. 1997. PMID: 9228664 Review. No abstract available.
The blood-brain barrier and multiple sclerosis.
Moor AC, de Vries HE, de Boer AG, Breimer DD. Moor AC, et al. Among authors: de boer ag. Biochem Pharmacol. 1994 May 18;47(10):1717-24. doi: 10.1016/0006-2952(94)90297-6. Biochem Pharmacol. 1994. PMID: 8204088 Review. No abstract available.
Interventions to enhance return-to-work for cancer patients.
de Boer AG, Taskila T, Tamminga SJ, Frings-Dresen MH, Feuerstein M, Verbeek JH. de Boer AG, et al. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007569. doi: 10.1002/14651858.CD007569.pub2. Cochrane Database Syst Rev. 2011. PMID: 21328297 Updated. Review.
294 results